In addition, this therapeutic approach also interfered with PD-1/PD-L1 pathway-regulated immune tolerance and suppression of CD8+ T cells, inducing the cancer cell lysis effect mediated by IFN-γ and TNF-α production. The gene discussed is CD274; the disease is cancer.